Étude portant sur le pembrolizumab chez des participants atteints de tumeurs solides avancées
In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475).